Bentham Science Logo

Contents

Current Drug Targets, Volume 19 - Number 1

Review Article   Free Content


Review Article   Free Content

PARP Inhibitor Drugs in the Treatment of Breast, Ovarian, Prostate and Pancreatic Cancers: An Update of Clinical Trials

, 19(1): 21 - 37

Dalia Kamel*, Christopher Gray, Jagdeep Singh Walia and Vikaash Kumar*


DOI: 10.2174/1389450118666170711151518



Review Article   Free Content


Review Article   Free Content


Review Article   Free Content

Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer

, 19(1): 70 - 80

Md Abul Barkat, Harshita, Javed Ahmad, Mohammad Ahmed Khan*, Sarwar Beg* and Farhan Jalees Ahmad*


DOI: 10.2174/1389450118666170612095959



Review Article   Free Content

Idarucizumab: What Should We Know?

, 19(1): 81 - 88

Francesca Cortese*, Giacinto Calculli, Michele Gesualdo, Annagrazia Cecere, Annapaola Zito, Fiorella De Vito, Rossella Carbonara, Santa Carbonara, Anna Maria Cortese and Marco Matteo Ciccone


DOI: 10.2174/1389450118666170925155943



Review Article   Free Content



Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science